HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masuda, M. Articles by Flameng, W. Search for Related Content PubMed PubMed Citation Articles by Masuda, M. Articles by Flameng, W.

The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 1610-1617, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts

M Masuda, C Chang-Chun, T Mollhoff, H Van Belle and W Flameng
Laboratory of Experimental Cardiac Surgery, Katholieke Universiteit Leuven, Belgium.

The effect of nucleoside transport inhibition on 24-hour preservation of canine hearts was studied in 36 hearts arrested either with a cold hyperkalemic cardioplegic solution without (group I) or with supplementation of a specific nucleoside transport inhibitor (R75231, 1 mg/L) (groups II and III). The hearts were excised and stored for 24 hours at 0.5 degrees C. Then they were reperfused for 3 hours with use of a closed perfusion system primed with normal blood (groups I and II) or with blood supplemented with the same nucleoside transport inhibitor (0.32 mg/L) (group III). Serial biopsy specimens for determination of myocardial purines were taken. Creatine kinase and heat-stable lactate dehydrogenase release from the myocardium were examined during reperfusion. Recovery of function was studied during reperfusion by measurement of isometric contraction in a fluid-filled intraventricular balloon. After 24 hours of preservation, without the use of the drug, myocardial inosine and hypoxanthine accumulated to, respectively, 4.05 +/- 1.18 and 0.28 +/- 0.08 mumol/gm dry weight. In the drug-treated groups (II and III pooled), significantly less inosine and hypoxanthine accumulated (1.68 +/- 0.33 and 0.05 +/- 0.02 mumol/gm dry weight, respectively) (p < 0.05 versus group I). Upon reperfusion, intramyocardial adenosine was lost in the control hearts and maintained in the drug-treated hearts. Hypoxanthine accumulated significantly (p < 0.05) during reperfusion in group I (1.08 +/- 0.43 versus 0.16 +/- 0.13 in group II and 0.03 +/- 0.03 mumol/gm dry weight in group III). The rate of creatine kinase and heat-stable lactate dehydrogenase release was significantly lower (p < 0.05) in group III (that is, pretreatment and posttreatment with the drug) than in the control group. Functional recovery of hearts in group III was superior to that in group II (p < 0.05), while hearts in group I showed no recovery at all. We conclude that nucleoside transport inhibition improves long-term preservation of the heart and that the mechanism of this protection may be related to an increase in endogenous adenosine and reduction of myocardial hypoxanthine content.

This article has been cited by other articles:

				Z. Zhu, P. A. Hofmann, and J. K. Buolamwini Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2921 - H2926. [Abstract] [Full Text] [PDF]

				S. E. Fremes, J. Zhang, R. D. Furukawa, D. A. G. Mickle, and R. D. Weisel ADENOSINE PRETREATMENT FOR PROLONGED CARDIAC STORAGEAn evaluation with St. Thomas' Hospital and University of Wisconsin solutions J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 293 - 301. [Abstract] [Full Text]

				S. E. Fremes, R. D. Furukawa, J. Zhang, R.-K. Li, L. C. Tumiati, R. D. Weisel, and D. A. G. Mickle Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker Ann. Thorac. Surg., May 1, 1995; 59(5): 1127 - 1133. [Abstract] [PDF]

				R. D. Lasley and R. M. Mentzer Jr. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1356 - 1363. [Abstract] [Full Text]